Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Metadata
Title
Integrated cardiac PET-CT for the diagnosis and management of CAD
Authors
Marcelo F. Di Carli
Sharmila Dorbala
Rory Hachamovitch
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 2/2006
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/BF02971234

Other articles of this Issue 2/2006

Journal of Nuclear Cardiology 2/2006 Go to the issue

Editorial

One size fits all?

OriginalPaper

Coronary artery disease and nuclear imaging in renal failure

Original Articles

Diagnostic accuracy of gated Tc-99m sestamibi stress myocardial perfusion SPECT with combined supine and prone acquisitions to detect coronary artery disease in obese and nonobese patients

Advances in Nonnuclear Imaging Technologies

Echocardiographic assessment of left ventricular function

OriginalPaper

Worsening of left ventricular ejection fraction induced by dipyridamole on Tl-201 gated myocardial perfusion imaging predicts significant coronary artery disease

OriginalPaper

Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits